Deutsche Bank analyst Emmanuel Papadakis maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target ...

Find out more about purpose in Telefónica, by Joaquín Rivera. Enter now to know his thoughts and don't miss it.

When Daniella Zucchetto was in her late 40s she found herself suddenly exhausted to the point where she was unable to get out of bed for weeks at a time. As a self-employed single mother, that was not ...

Axsome Therapeutics, Inc. , a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will host a virtual investor event and conference call today at ...

DRG Instruments GmbH ("DRG") has been a top developer and manufacturer of immunoassays for over 50 years. The company is creating a new division, DRG Neuroscience, and the new division is presenting ...

Represents net earnings attributable to AbbVie Inc. Intangible asset impairment reflects a partial after-tax impairment charge of $3.5 billion related to the emraclidine intangible asset acquired as ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

There are still unanswered questions about rebuilding, how to make up for three weeks of lost in-person schooling, and how ...

AbbVie Inc. ABBV reported fourth-quarter 2024 adjusted earnings of $2.16 per share, which beat the Zacks Consensus Estimate of $2.13. The reported earnings also exceeded the company’s guidance of ...

By creating powerful art that more appropriately considers and depicts mental health challenges, Hollywood could use its great power more responsibly.

The global immunohistochemistry (IHC) market is expected to grow from USD 3.5 billion in 2024 to USD 7.4 billion by 2034, reflecting a CAGR of 7.8% over the forecast period. Request a Sample Copy of ...